Spotlight

French Biotech: In Pursuit of Funding

With government funding in limited supply, biotech companies in France have developed strategies to build financial muscle and ensure their economic vision for the future.

India's Road to Success

India is establishing itself as a global leader for pharmaceutical research, and increasingly, commercialization.

HIV/AIDS in South Africa: Progress Through Collaboration

As South Africa grapples with the world’s largest population suffering with HIV/AIDS, pharmaceutical manufacturers and non-government organizations are working together to fight the pandemic and search for a cure.

The Path to Collaboration

The initial projects of the Critical Path Initiative are helping to build a foundation for more modernized drug development.

A Window of Opportunity

The cooperative efforts of government agencies, pharmaceutical manufacturers and academic researchers are helping to modernize Japan’s drug development climate.

Adaptive Design: In Theory and Practice

Adaptive trial design has the potential to reduce costs, save time and enable greater patient safety … but only if thoroughly planned and properly executed.

Navigating Rocky Terrain

Many clinical trial sponsors are heading to Latin America—but there are still plenty of obstacles to overcome.

Click here for a special report
Contact

Recieve Free E-mail Updates


Subscribe to Our Newsletter

Web Exclusives

An Unbalanced Burden

A Q&A with Dr. Kathleen Squires, director of the infectious disease department at Jefferson Medical College in Philadelphia, illuminates the gender differences in the diagnosis and treatment of HIV.

Turning the Corner

After decades of neglect, leading to a rapid increase in incidence, tuberculosis started gaining attention from industrialized nations over the past 10 years. With this new focus, TB’s incidence has started to decrease—but barely.

Articles